Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109096162B details a mild Scandium(III) catalyzed synthesis of sulfur-containing intermediates, offering cost reduction in API manufacturing and scalable production.
Novel elemental sulfur-promoted synthesis reduces costs and enhances safety for high-purity pharmaceutical intermediates manufacturing supply chains.
Patent CN115353482B reveals metal-free synthesis for high-purity spirocyclic intermediates. Enables cost reduction and scalable supply chain for pharmaceutical manufacturing.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112694430B details a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high yields and simplified processing for API manufacturing.
Patent CN114478378A details a green water-based cyclization method for isoquinolines, offering cost-effective pharma intermediate manufacturing solutions.
Patent CN112898192B reveals a safe, efficient palladium-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel Pd-catalyzed one-pot method ensures high purity and scalable production for pharmaceutical intermediates with significant cost advantages.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN112812032A reveals a green route to acetamides using dimethyl carbonate, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN112047879B details a novel copper-catalyzed method for selective halogenation, offering cost-effective and scalable solutions for API intermediate manufacturing.
Novel patent CN107880039B enables heavy-metal-free synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN108558635B reveals a transition-metal-free route for 3-arylpropynoic acids using atmospheric CO2, offering significant cost reduction and supply chain reliability.
Novel ionic liquid catalysis enables efficient indoloindolazinone synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115403505B details novel thioester synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN117164506B details palladium catalyzed carbonylation for indeno indole one. Efficient route ensures cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel room temperature nitration process enhances purity and yield. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.